This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kenneth Shoemaker: Innovator in Chromatography Systems
Introduction
Kenneth Shoemaker is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of chromatography, particularly through his innovative patent. His work focuses on enhancing manufacturing processes in the pharmaceutical industry.
Latest Patents
Kenneth Shoemaker holds a patent for "Parallel chromatography systems and methods." This patent describes advanced parallel chromatography systems and continuous manufacturing methods that utilize two or more chromatography column skids. These systems operate in parallel, with automation controls that determine which column to load at any given time. This innovation aims to improve efficiency and effectiveness in chromatography processes.
Career Highlights
Kenneth has had a successful career, working at Amgen Inc., a leading biotechnology company. His role at Amgen has allowed him to apply his expertise in chromatography to develop solutions that enhance drug manufacturing processes. His contributions have been instrumental in advancing the capabilities of the company in the biopharmaceutical sector.
Collaborations
Throughout his career, Kenneth has collaborated with several talented individuals, including John B Flynn and Neil Soice. These collaborations have fostered an environment of innovation and have led to the development of cutting-edge technologies in the field.
Conclusion
Kenneth Shoemaker's work in chromatography systems exemplifies the impact of innovation in the biotechnology industry. His patent and contributions to Amgen Inc. highlight the importance of continuous improvement in manufacturing processes. Kenneth's dedication to advancing technology in this field is commendable and reflects the spirit of innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
